Article: Provectus Pharmaceuticals 10Q Highlights New Financial Capability.

Company Obtains Financing Which Alleviates Doubt About Its Ability to Continue as a Going Concern

Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT) announced today that it has obtained the necessary financing to support its planned operations and research activities which alleviates the doubt concerning its ability to operate in the future, as discussed in the company's second quarter 2004 financial statements released yesterday in its form 10-QSB.

Provectus Pharmaceuticals, Inc. licenses and sells products in three sectors of the health-care industry: 1) prescription medications and treatments, 2) medical devices, and 3) over-the-counter (OTC) ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!